Cardiac ion channels

Circulation: Arrhythmia and Electrophysiology

Volumn 2, Issue 2, 2009, Pages 185-194

  Grant, Augustus O ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Action potentials; Electrocardiography; Electrophysiology; Genetics; Ion channels

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; DOFETILIDE; FLECAINIDE; IBUTILIDE; ION CHANNEL; LIDOCAINE; METOPROLOL; PROCAINAMIDE; SODIUM CHANNEL; VERAPAMIL;

CHANNEL GATING; GAP JUNCTION; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HUMAN; HYPERPOLARIZATION; ION PERMEABILITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HUMANS; ION CHANNELS;

EID: 70349452265     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.108.789081     Document Type: Review

References (47)

1. Hoffman BF, Cranefield PF. Electrophysiology of the Heart. New York: McGraw-Hill Book Company; 1960:1-323.
2. Antzelevitch C, Dumaine R. Electrical heterogeneity in the heart: physiological, pharmacological and clinical implications. In: Handbook of Physiology. New York: Oxford University Press; 2002: Chapter 17.
3. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992; 8:690-695.
4. Hille B. Ionic Channels of Excitable Membranes. Sunderland: Sinauer Associates Inc; 1984:249 -271.
5. Lopatin AN, Makhina EN, Nichols CG. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature. 1994; 372:366 -369.
6. Leblanc N, Hume JR. Sodium current-induced release of calcium from cardiac sarcoplasmic reticulum. Science. 1990; 248:372-376.
7. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Markes AR, Kass RS. Requirement of a Macromolecular Signaling Complex for - Adrenergic Receptor Modulation of the KCNQ1-KCNE1 Potassium Channel. Science. 2002; 295:496-499.
8. Delmar M, Duffy HS, Sorgen PL, Taffet SM, Spray DC. Molecular organization and regulation of the cardiac gap junction channel connexin43. In: Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: Elsevier Inc; 2004.
9. Mohler PJ, Splawski I, Napolitano C, Bottelli G, Sharpe L, Timothy K, Priori SG, Keating MT, Bennett V. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A. 2004; 101:9137-9142.
10. Hodgkin AL, Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol. 1952; 117:500 -544.
11. Noda M, Shimizu S, Tanabe T, Takai T, Kayano T, Ikeda T, Takahashi H, Nakayama H, Kanaoke Y, Minamino N, Kangawa R, Matsuo H, Raftery MA, Hirose T, Inayama S, Hayashida H, Miyata T, Numa S. Primary structure of electrophorus electricus sodium channel deduced from cDNA sequence. Nature. 1984; 312:121-127.
12. Li RA, Tomaselli F, Marbin E. Sodium Channels. In: Cardiac electrophysiology: from cell to bedside. 2004. Elsevier, Inc., Philadelphia, PA.
13. Patlak JB, Ortiz M. Slow currents through single sodium channels of adult rat heart. J Gen Physiol. 1985; 86:89 -104.
14. Grant AO, Starmer CF. Mechanisms of closure of cardiac sodium channels in rabbit ventricular myocytes: Single-channel analysis. Circ Res. 1987; 60:897-913.
15. Zilberter YI, Starmer CF, Starobin J, Grant AO. Late Na channels in cardiac cells: The physiological role of background Na channels. Biophys J. 1994; 67:153-160.
16. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995; 376:683- 685.
17. Richmond JE, Featherstone DE, Hartmann HA, Ruben PC. Slow inactivation in human cardiac sodium channels. Biophys J. 1998; 74: 2945-2952.
18. Rohl CA, Boeckman FA, Baker C, Scheuer T, Catterall WA, Klevit RE. Solution structure of the sodium channel inactivation gate. Biochemistry. 1999; 38:855- 861. (Pubitemid 29052698)
19. +- channel inactivation. Proc Natl Acad Sci U S A. 1992; 89:10910 -10914.
20. Ono K, Kiyosue T, Arita M. Isoproterenol, DBcAMP and forskolin inhibit cardiac sodium current. Am J Physiol. 1989; 256:C1131-C1137.
21. Kirstein M, Eickhorn R, Kochsiek K, Langenfeld H. Dose-dependent alteration of rat cardiac sodium current by isoproterenol: results from direct measurements on multicellular preparations. Eur J Physiol. 1996; 431:395- 401.
22. Frohnwieser B, Chen, L-Q, Schreibmayer W, Kallen RG. Modulation of the human cardiac sodium channel a-subunit by cAMP-dependent protein kinase and the responsible sequence domain. J Physiol. 1997; 498: 309-318.
23. + current and causes inherited arrhythmias. Circulation. 2007; 116:2260 -2268.
24. + Channels. Physiol Rev. 2005; 85: 33-47.
25. + channel blockade and to increases in heart rate. Circulation. 1995; 92:3381-3386.
26. Wang DW, Yazawa K, Makita N, George AL Jr, Bennett PB. Pharmacological targeting of long QT mutant sodium channels. J Clin Invest. 1997; 99:1714 -1720.
27. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Riera ARP, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada Syndrome: Report of the Second Consensus Conference. Heart Rhythm. 2005; 2:429-440. (Pubitemid 40439292)
28. Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol. 2005; 16:394 -396.
29. Zhang, Z-S, Tranquillo J, Neplioueve V, Bursac N, Grant A. Sodium channel Kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease. Am J Physiol Heart Circ Physiol. 2007; 292:H399-H407.
30. Schott, J-J, Alshinawi C, Kyndt F. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet. 1999; 23:20 -21.
31. Grant AO, Carboni MP, Neplioueva V, Starmer CF, Memmi M, Napolitano C, Priori S. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest. 2002; 110:1201-1209.
32. McNair WP, Ku L, Taylor MRG, Fain PR, Dao D, Wolfel E, Mestroni L. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation. 2004; 110:2163-2167.
33. Hondeghem LM, Katzung BG Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977; 472:373-398.
34. Starmer CF, Grant AO. Phasic ion channel blockade: A kinetic and parameter estimation procedure. Mol Pharmacol. 1985; 28:348 -356.
35. Harrison DC. Is there a rational basis for the modified classification of antiarrhythmic drugs? In: Morganroth J, Moore EN, eds. New Drugs and Devices. Boston: Martinus Nijhoff; 1985.
36. Heinemann SH, Terlau H, Stuhmer W, Imoto K, Numa S. Calcium channel characteristics conferred on the sodium channel by single mutations. Nature. 1992; 356:441- 443.
37. Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A. 2005; 102:8089-8096.
38. Erxleben C, Liao Y, Gentile S, Chin D, Gomez-Alegria C, Mori Y, Birnbaumer L, Armstrong DL. Cyclosporin and Timothy syndrome increase mode 2 gating of CaV1.2 calcium channels through aberrant phosporylation of S6 helices. Proc Natl Acad Sci U S A. 2006; 103: 3932-3937.
39. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr, Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu, L-F, Haï ssaguerre M, Schimpf R, Borggrefe M, Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007; 115:442- 449.
40. Splawski I, Shen, j, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT. Spectrum of mutations in Long-QT syndrome genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000; 102:1178 -1185.
41. Herrmann S, Stieber J, Ludwig A. Pathophysiology of HCN channels. Eur J Physiol. 2007; 454.
42. Rohr S. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc Res. 2004; 62:309 -322.
43. Spach M. Anisotropy of cardiac tissue: a major determinant of conduction? J Cardiovasc Electrophysiol. 1999; 10:887- 890.
44. Nattel S, Carlsson L. Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov. 2006; 5:1034 -1049.
45. Donahue JK, Heldman AW, Fraser H, McDonald AD, Miller JM, Rade JJ, Eschenhagen T, Marban E. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med. 2000; 6:1395-1398.
46. Herbert E, Chahine M. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts. Can J Physiol Pharmacol. 2006; 84:795- 802.
47. Rosen MR, Brink PR, Cohen IS, Robinson RB. Cardiac pacing from electronic . . . to biological circulation: arrhythmia and electrophysiology. Circ Arrhythmia Electrophysiol. 2008; 1:54-61.